胰岛素输液泵市场 - 增长、趋势、COVID-19 影响和预测 (2023 - 2028)

市场按组件（泵装置、输液器和储液器）和地理位置进行细分。

Home right-chevron-icon Industry Reports right-chevron-icon Healthcare right-chevron-icon Medical Devices right-chevron-icon Global Insulin Infusion Pumps Market right-chevron-icon 胰岛素输液泵市场

市场快照

insulin infusion pump market trends
Study Period: 2018 - 2026
Fastest Growing Market: North America
Largest Market: North America
CAGR: 0 %

Major Players

insulin infusion pump market major players

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

  • 在预测期内，胰岛素输液泵市场的复合年增长率将达到 7.51%。胰岛素输注泵可替代传统的每日注射系统或胰岛素笔。
  • 胰岛素输液泵可减少血糖水平的大幅波动，减轻疼痛，并且比注射更准确地输送。使用泵时不需要安排用餐时间。
  • 这使得输液泵对患者来说更加用户友好。胰岛素治疗也称为持续皮下胰岛素输注 (CSII)。它是一种高效灵活的胰岛素输送方法。
  • 胰岛素泵已经发展并且比以前更可靠。CSII 技术见证了许多技术进步，例如将连续血糖监测与泵相结合。现在，胰岛素泵可以在分析血糖读数后控制自动输送胰岛素的算法

报告范围

胰岛素输液泵市场分为设备、输液器和储液器。该报告还分为五个区域：北美、亚太地区、欧洲、中东和非洲以及拉丁美洲。

By Product (Value and Volume, 2012-2024)
Insulin Pumps
Infusion Sets
Reservoirs
Geography
North America
United States (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Canada (Value and Volume, 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of North America (Value and Volume, 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Asia - Pacific
Japan (Value and Volume, 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Korea (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
China (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
India (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Australia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Vietnam (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Malaysia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Indonesia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Philippines (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Thailand (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Asia - Pacific (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Europe
United Kingdom (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
France (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Germany (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Italy (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Spain (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Russia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Europe (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Latin America
Mexico (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Brazil (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Latin America (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Middle East & Africa
Saudi Arabia (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Iran (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Egypt (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Oman (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Africa (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Middle East & Africa (Value and Volume, 2012 - 2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs

Report scope can be customized per your requirements. Click here.

主要市场趋势

胰岛素泵市场在预测期内的复合年增长率为 7%

  • 由于肥胖率的上升、2型糖尿病的遗传因素增加以及1型糖尿病患者人数的增加，胰岛素输液泵市场可能会继续增长。 
  • 1 型糖尿病人群中胰岛素泵的使用率很高。它也在 2 型患者中增长。儿童与成人或 1 型与 2 型患者使用胰岛素泵的比例因国家而异。
insulin infusion pump market analysis

竞争格局

  • Animas 不得不退出胰岛素泵市场，因为该公司承认竞争加剧是他们离开市场的原因。
  • 美敦力是市场领导者，预计在预测期内将保持其地位。

主要玩家

  1. Medtronic

  2. Roche

  3. Animas

  4. Ypsomed

  5. Insulet

*Disclaimer: Major Players sorted in no particular order

Medtronic Roche Animas Ypsomed Insulet

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product (Value and Volume, 2012-2024)

      1. 5.1.1 Insulin Pumps

      2. 5.1.2 Infusion Sets

      3. 5.1.3 Reservoirs

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value and Volume 2012-2024)

          1. 5.2.1.1.1 By Insulin Pump Devices

          2. 5.2.1.1.2 By Infusion Sets

          3. 5.2.1.1.3 By Reservoirs

        2. 5.2.1.2 Canada (Value and Volume, 2012-2024)

          1. 5.2.1.2.1 By Insulin Pump Devices

          2. 5.2.1.2.2 By Infusion Sets

          3. 5.2.1.2.3 By Reservoirs

        3. 5.2.1.3 Rest of North America (Value and Volume, 2012-2024)

          1. 5.2.1.3.1 By Insulin Pump Devices

          2. 5.2.1.3.2 By Infusion Sets

          3. 5.2.1.3.3 By Reservoirs

      2. 5.2.2 Asia - Pacific

        1. 5.2.2.1 Japan (Value and Volume, 2012-2024)

          1. 5.2.2.1.1 By Insulin Pump Devices

          2. 5.2.2.1.2 By Infusion Sets

          3. 5.2.2.1.3 By Reservoirs

        2. 5.2.2.2 South Korea (Value and Volume 2012-2024)

          1. 5.2.2.2.1 By Insulin Pump Devices

          2. 5.2.2.2.2 By Infusion Sets

          3. 5.2.2.2.3 By Reservoirs

        3. 5.2.2.3 China (Value and Volume, 2012 - 2024)

          1. 5.2.2.3.1 By Insulin Pump Devices

          2. 5.2.2.3.2 By Infusion Sets

          3. 5.2.2.3.3 By Reservoirs

        4. 5.2.2.4 India (Value and Volume, 2012 - 2024)

          1. 5.2.2.4.1 By Insulin Pump Devices

          2. 5.2.2.4.2 By Infusion Sets

          3. 5.2.2.4.3 By Reservoirs

        5. 5.2.2.5 Australia (Value and Volume, 2012 - 2024)

          1. 5.2.2.5.1 By Insulin Pump Devices

          2. 5.2.2.5.2 By Infusion Sets

          3. 5.2.2.5.3 By Reservoirs

        6. 5.2.2.6 Vietnam (Value and Volume, 2012 - 2024)

          1. 5.2.2.6.1 By Insulin Pump Devices

          2. 5.2.2.6.2 By Infusion Sets

          3. 5.2.2.6.3 By Reservoirs

        7. 5.2.2.7 Malaysia (Value and Volume, 2012 - 2024)

          1. 5.2.2.7.1 By Insulin Pump Devices

          2. 5.2.2.7.2 By Infusion Sets

          3. 5.2.2.7.3 By Reservoirs

        8. 5.2.2.8 Indonesia (Value and Volume, 2012 - 2024)

          1. 5.2.2.8.1 By Insulin Pump Devices

          2. 5.2.2.8.2 By Infusion Sets

          3. 5.2.2.8.3 By Reservoirs

        9. 5.2.2.9 Philippines (Value and Volume, 2012 - 2024)

          1. 5.2.2.9.1 By Insulin Pump Devices

          2. 5.2.2.9.2 By Infusion Sets

          3. 5.2.2.9.3 By Reservoirs

        10. 5.2.2.10 Thailand (Value and Volume, 2012 - 2024)

          1. 5.2.2.10.1 By Insulin Pump Devices

          2. 5.2.2.10.2 By Infusion Sets

          3. 5.2.2.10.3 By Reservoirs

        11. 5.2.2.11 Rest of Asia - Pacific (Value and Volume, 2012 - 2024)

          1. 5.2.2.11.1 By Insulin Pump Devices

          2. 5.2.2.11.2 By Infusion Sets

          3. 5.2.2.11.3 By Reservoirs

      3. 5.2.3 Europe

        1. 5.2.3.1 United Kingdom (Value and Volume, 2012 - 2024)

          1. 5.2.3.1.1 By Insulin Pump Devices

          2. 5.2.3.1.2 By Infusion Sets

          3. 5.2.3.1.3 By Reservoirs

        2. 5.2.3.2 France (Value and Volume, 2012 - 2024)

          1. 5.2.3.2.1 By Insulin Pump Devices

          2. 5.2.3.2.2 By Infusion Sets

          3. 5.2.3.2.3 By Reservoirs

        3. 5.2.3.3 Germany (Value and Volume, 2012 - 2024)

          1. 5.2.3.3.1 By Insulin Pump Devices

          2. 5.2.3.3.2 By Infusion Sets

          3. 5.2.3.3.3 By Reservoirs

        4. 5.2.3.4 Italy (Value and Volume, 2012 - 2024)

          1. 5.2.3.4.1 By Insulin Pump Devices

          2. 5.2.3.4.2 By Infusion Sets

          3. 5.2.3.4.3 By Reservoirs

        5. 5.2.3.5 Spain (Value and Volume, 2012 - 2024)

          1. 5.2.3.5.1 By Insulin Pump Devices

          2. 5.2.3.5.2 By Infusion Sets

          3. 5.2.3.5.3 By Reservoirs

        6. 5.2.3.6 Russia (Value and Volume, 2012 - 2024)

          1. 5.2.3.6.1 By Insulin Pump Devices

          2. 5.2.3.6.2 By Infusion Sets

          3. 5.2.3.6.3 By Reservoirs

        7. 5.2.3.7 Rest of Europe (Value and Volume, 2012 - 2024)

          1. 5.2.3.7.1 By Insulin Pump Devices

          2. 5.2.3.7.2 By Infusion Sets

          3. 5.2.3.7.3 By Reservoirs

      4. 5.2.4 Latin America

        1. 5.2.4.1 Mexico (Value and Volume, 2012 - 2024)

          1. 5.2.4.1.1 By Insulin Pump Devices

          2. 5.2.4.1.2 By Infusion Sets

          3. 5.2.4.1.3 By Reservoirs

        2. 5.2.4.2 Brazil (Value and Volume, 2012 - 2024)

          1. 5.2.4.2.1 By Insulin Pump Devices

          2. 5.2.4.2.2 By Infusion Sets

          3. 5.2.4.2.3 By Reservoirs

        3. 5.2.4.3 Rest of Latin America (Value and Volume, 2012 - 2024)

          1. 5.2.4.3.1 By Insulin Pump Devices

          2. 5.2.4.3.2 By Infusion Sets

          3. 5.2.4.3.3 By Reservoirs

      5. 5.2.5 Middle East & Africa

        1. 5.2.5.1 Saudi Arabia (Value and Volume, 2012 - 2024)

          1. 5.2.5.1.1 By Insulin Pump Devices

          2. 5.2.5.1.2 By Infusion Sets

          3. 5.2.5.1.3 By Reservoirs

        2. 5.2.5.2 Iran (Value and Volume, 2012 - 2024)

          1. 5.2.5.2.1 By Insulin Pump Devices

          2. 5.2.5.2.2 By Infusion Sets

          3. 5.2.5.2.3 By Reservoirs

        3. 5.2.5.3 Egypt (Value and Volume, 2012 - 2024)

          1. 5.2.5.3.1 By Insulin Pump Devices

          2. 5.2.5.3.2 By Infusion Sets

          3. 5.2.5.3.3 By Reservoirs

        4. 5.2.5.4 Oman (Value and Volume, 2012 - 2024)

          1. 5.2.5.4.1 By Insulin Pump Devices

          2. 5.2.5.4.2 By Infusion Sets

          3. 5.2.5.4.3 By Reservoirs

        5. 5.2.5.5 South Africa (Value and Volume, 2012 - 2024)

          1. 5.2.5.5.1 By Insulin Pump Devices

          2. 5.2.5.5.2 By Infusion Sets

          3. 5.2.5.5.3 By Reservoirs

        6. 5.2.5.6 Rest of Middle East & Africa (Value and Volume, 2012 - 2024)

          1. 5.2.5.6.1 By Insulin Pump Devices

          2. 5.2.5.6.2 By Infusion Sets

          3. 5.2.5.6.3 By Reservoirs

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2012-2024)

    2. 6.2 Type-2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Medtronic

      2. 7.1.2 Insulet

      3. 7.1.3 Roche

      4. 7.1.4 Animas

      5. 7.1.5 Tandem

      6. 7.1.6 Ypsomed

      7. 7.1.7 Cellnovo

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Animas

      3. 7.2.3 Medtronic

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

从 2018 年到 2028 年研究了全球胰岛素输液泵市场。

未来 5 年，全球胰岛素输液泵市场的复合年增长率将超过 6.2%。

2018 年全球胰岛素输液泵市场价值 30 亿美元。

2028 年全球胰岛素输液泵市场价值 40 亿美元。

北美在 2018 年至 2028 年的复合年增长率最高。

北美在 2021 年的份额最高。

Medtronic PLC、Insulet Corporation、Tandem Diabetes Care、Ypsomed、Ascensia Diabetes Care 是在全球胰岛素输液泵市场运营的主要公司。

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!